Experimental and Therapeutic Medicine · 2013 · 60 citations · 28 references
Life SciencesImmunologyPharmacologyInflammationInnate ImmunityNeuroimmunologyCytokine BiologyInflammatory SignalingInnate Immune ModulationMicroglia BiologyNeuroinflammationToll-like ReceptorsAnti-inflammatory ActivityAnti-inflammatory MechanismsInflammatory Cytokine ProductionMicroglia ActivationMyd88-dependent SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B InhibitionNuclear Factor Kappa B Modulation
Ganoderma lucidum is a traditional Oriental medicine that has been widely used as a tonic to promote longevity and health in Korea and other Asian countries. Although a great deal of work has been carried out on the therapeutic potential of this mushroom, the pharmacological mechanisms of its anti-inflammatory actions remain unclear. In this study, we evaluated the inhibitory effects of G. lucidum ethanol extract (EGL) on the production of inflammatory mediators and cytokines in lipopolysaccharide (LPS)-stimulated murine BV2 microglia. We also investigated the effects of EGL on the LPS-induced activation of nuclear factor kappaB (NF-κB) and upregulation of toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88). Elevated levels of nitric oxide (NO), prostaglandin E(2) (PGE(2)) and pro-inflammatory cytokine production were detected in BV2 microglia following LPS stimulation. We identifed that EGL significantly inhibits the excessive production of NO, PGE(2) and pro-inflammatory cytokines, including interleukin (IL)-1β and tumor necrosis factor-α in a concentration-dependent manner without causing cytotoxicity. In addition, EGL suppressed NF-κB translocation and transcriptional activity by blocking IκB degradation and inhibiting TLR4 and MyD88 expression in LPS-stimulated BV2 cells. Our results indicate that the inhibitory effects of EGL on LPS-stimulated inflammatory responses in BV2 microglia are associated with the suppression of the NF-κB and TLR signaling pathways. Therefore, EGL may be useful in the treatment of neurodegenerative diseases by inhibiting inflammatory mediator responses in activated microglia.
28
Activation of microglial cells by β-amyloid protein and interferon-γ
Lucia Meda, Marco A. Cassatella, Györgyi I. Szendrei et al. · Nature · 1995 · 1.3K citations
The Lancet · 1999 · 1.2K citations
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
Makoto Sawada, Noriaki Kondo, Akio Suzumura et al. · Brain Research · 1989 · 630 citations